PMID- 16527169
OWN - NLM
STAT- MEDLINE
DCOM- 20060728
LR  - 20190917
IS  - 0014-2565 (Print)
IS  - 0014-2565 (Linking)
VI  - 206
IP  - 2
DP  - 2006 Feb
TI  - [Current indications of heparin treatment].
PG  - 98-9
AB  - The last guidelines on treatment of venous thromboembolic disease recommend the 
      use of unfractionated heparin (UFH) or low molecular weight heparin (LMWH). In 
      the case of deep venous thrombosis in out-patients, LMWH is preferred, associated 
      to dicumarinics from the first day. In regards to prophylaxis, administration of 
      UFH or LMWH is recommended in surgical patients of moderate to high risk but not 
      in those undergoing minor surgery, under 40 years and without other risk factors. 
      In patients with acute coronary syndrome without ST elevation, the administration 
      of LMWH at fixed doses together with platelet antiaggregants is recommended. In 
      patients with acute cerebral ischemia and without other criteria for thrombolytic 
      treatment, treatment with heparin is not recommended but rather the 
      administration of platelet antiaggregants.
FAU - Monreal Bosch, M
AU  - Monreal Bosch M
AD  - Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, 
      Badalona, Barcelona. mmonreal.germanstrias@gencat.net
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Indicaciones actuales del tratamiento con heparinas.
PL  - Spain
TA  - Rev Clin Esp
JT  - Revista clinica espanola
JID - 8608576
RN  - 0 (Anticoagulants)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Anticoagulants/*therapeutic use
MH  - Heparin/*therapeutic use
MH  - Humans
MH  - Thromboembolism/*drug therapy/etiology
EDAT- 2006/03/11 09:00
MHDA- 2006/07/29 09:00
CRDT- 2006/03/11 09:00
PHST- 2006/03/11 09:00 [pubmed]
PHST- 2006/07/29 09:00 [medline]
PHST- 2006/03/11 09:00 [entrez]
AID - 13085361 [pii]
AID - 10.1157/13085361 [doi]
PST - ppublish
SO  - Rev Clin Esp. 2006 Feb;206(2):98-9. doi: 10.1157/13085361.